Vesiculobolous lesions Flashcards

1
Q

Herpes Simplex Infection

A

primary infection is the initial systemic infection, and secondary is the localized reactivation in a previously infected person. an immunocompromised host may develop severe secondary disease.
control of symptoms not cure is the goal, as the virus stays latent in the nerves
the virus spreads through exposure to body fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Herpes simplex infection progression

A

primary infection affects the skin, vermilion, and the oral mucous membranes, on any mucosal surface
Secondary lesions are confined to the lips, hard palate, and gingiva, healing in 1-2 weeks.
in immunodeficient patients secondary HSV1 results in significant pain and discomfort, can be chronic, destructive, and extensive.
Herpetic whitlow is an infection of the fingers through a break in the skin integrity. They form vesicles or pustules that eventually become ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Herpes simplex virus Histology

A

intraepithelial vesicles containing exudate, inflammatory cells, and characteristic virus-infected epithelial cells are seen
Virus-infected keratinocytes contain one or more homogenous, glassy nuclear inclusions that can be found on cytologic preparations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Herpes simplex virus differential

A

streptococcal pharyngitis (does not involve the lips or perioral tissues, and vessicles do not precede ulcers)
erythema multiforme (ulcers are larger, usually without a vesicular stage, and are less likely to affect the gingiva)
acute necrotizing ulcerative gingivitis (lesions are more limited to the gingiva, not preceded by vesicles)
Apthos stomatitis (usually multiple lesions, neurologic prodrome (tingling), vesicles preceding ulcers, and palatal and gingival location are indicative of HSV, and apthae are almost exclusively on nonkeratinized mucosa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Herpes simplex diagnosis

A

Tzanck smear
Serology
viral culture
immunohistochemistry
PCR testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Herpes simplex virus treatment

A

if no later than 48-72 hours prior to symptoms, then Acyclovir 5% ointment
5X/day topicaly
systemic acyclovir 400mg TID can be used for primary infections (usually HSV2)
for immunosupressed patients prophylactic acyclovir may be needed.
in HIV patients IV acyclovir may be needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Varicella Zoster pathogenesis

A

transmitted through direct contact by contaminated droplets from skin lesions
the virus proliferates within macrophages over a 2 week incubation period
host defenses are overcome, and systemic signs and symptoms develop.
It can reside asymptomatically int eh sensory ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Varicella Zoster clinical features

A

fever, chills, malaise, and headache accompany rash primarily in the trunk, head and neck
the rash becomes a vesicular eruption that forms pustules, and eventually ulcerates.
Secondary bacterial infections are common, and may result in scar formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Herpes Zoster

A

occurs through the branches of the nerves
can inovlve the trigeminal nerve, and resuts in unilateral oral, facial ,r occular lesions
remission usually occurs in several weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Varacella Zoster Histopathology

A

same as HSV
virus infected epithelial cells have homogenous nuclei representing viral products
multinucleation of infected cells is typical
Acantholytic vesicles break down and ulcerate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Varicella Zoster Differential

A

diagnosed by history of exposure, and type/distribution of lesions.
DD: primary HSV infection
hand-foot and mouth disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Varicella Zoster treatment

A

Supportive therapy is indicated
for immunocompromised patients, anti-viral therapies are warranted, including systemic acyclovir, vidarabine, and interferon.
Corticosteriods are contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hand-foot-and-mouth disease etiology

A

Coxsacki virus
transmitted through direct contact with nasal secretions
predilection for mucous membranes of the mouth (buccal mucosa and tongue) and cutaneous regions of the hands and feet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hand-foot-and mouth clinical features

A

resolves spontaneously in 1-2 weeks
usually occurs in children younger than 5
The lesions progress to a vesicular state, then become ulcerated, then encrusted lesions without later scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hand-foot-and-mouth histopathology

A

the vesicles are found in the epithelium due to obligate viral replication in keratinocytes
as keratinocytes are destroyed the vesicle enlarges and becomes filled with proteinaceous debris and inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hand-foot-and-mouth differential

A

primary herpetic gingivostomatitis
varicella Zoster

17
Q

hand-foot-and-mouth treatment

A

no specific treatment, only of symptoms
bicarbonate mouth rinses may help

18
Q

measles etiology

A

spread by airborne droplets
rash consists of pinpoint elevations over the soft palate that coalesce with involvement of the pharynx with bright erythema

19
Q

measles clinical features

A

the lesion spots of the buccal mucosa are known as Kiplik’s spots
complications of the virus include encephalitis and thrombocytopenic purpura

20
Q

Measles Histopathology

A

infected epithelial cells which become necrotic, overlie an inflamed connective tissue that contains dilated vascular channels and a focal inflammatory response

21
Q

measles differential diagnosis

A

prodromal symptoms, Koplik’s spots, and rash in unvaccinated individuals is sufficient evidence, but laboratory testing can confirm virus

22
Q

Pemphigus Vulgaris etiology

A

mucocutaneous disease characterized by intraepihtelial blister formation from a loss of intercellular keratinocyte adhesion
Produces epithelial cell separation (acantholysis)
circulating autoantibodies of IgG reat against composnents of epithelial desmosome-tonofilament complexes
the extent of epithelial cell separation is proportional to teh titer of circulating pemphigus antibodies

23
Q

pemphigus vulgaris clinical features

A

painful ulcers preceded by flaccid and short lived intraoral vesicles and bullae
Bullae rapidly rupture following their fomration ,eaving a red, painful ulcerated base with a friable epithelial border
lesions range from small apthos like lesions to large irregular map-like lesions
can occur with other autoimmune diseases such as myasthenia gravis, lupus erythematosus, rheumatoid arthritis, Hashimoto’s thyroiditis, thyroma, Sjogrens syndrome

24
Q

pemphigus vulgaris histopathology

A

interepithelial clefting iwth keratinocyte acantholysis
loss of desmosomal attachment of tonofilaments, resulting in free floating Tzanck cells
the basal layer remains attached to the basement membrane

direct immunofluorescent testing can diagnose, where a sample is tested for circulating antibodies of IgG type.

25
Q

pemphigus vulgaris differential

A

mucous membrane pemphigoid
erythema multiforme
erosive lichen planus
paraneoplastic pemphigus
apthos ulcers

26
Q

pemphigus vulgaris treatment

A

systemic corticosteroids
these medications do have their own associated long term morbidity
topical corticosteroids can be used judiciously, but long term use does have complications, and antifungal therapy may be needed

27
Q

Mucous membrane pemphigoid etiology

A

autoimmune process with unknown stimulus or etiology
deposits of immunoglobulins and compliment in teh basement zone.
targers include laminin 332

28
Q

Mucous Membrane Pemphigoid clinical features

A

other mucosal sites affected are conjunctiva, nasopharynx, larynx, esophagus, and ano-genital region
Oral lesions typically rpesent as superficial ulcers, Bullae are not always observed, blisters are fragile and short lived
THe lesions are chronic and persistant, and may scar

29
Q

Mucous Membrane Pemphigoid histopathology

A

subepithelial clefting disorder without acantholysis. few lymphocytes are seen initially but the infiltrate becomes more dense and mixed over time

30
Q

Mucous Membrane Pemphigoid differential

A

pemphigus vulgaris
erosive lichen planus
if lesion only in attached gingiva
atropic lichen planis
linear IgA disease
discoid lupus erythematosus
contact allergy

31
Q

Mucous membrane Pemphigoid treatment

A

Corticosteroids are typically used to control. Prednisone for moderate to severe disease, topical steroids for mild disease and maintenance
Note the possible appearance of ocular disease, so ophthalmic evaluation is important

32
Q

Bullous Pemphigoid etiology

A

closely related to mucous membrane pemphigoid, but titers of circulating autoantibodies to the basement membrane zone antigens are detectable.
lesions cannot be differentiated from mucous membrane pemphigoid

33
Q

Bullous Pemphigoid histopathology

A

the lesions are similar to mucous membrane pemphigoid
the basement membrane is cleaved at the level of the lamina lucida

34
Q

Bullous Pemphigoid treatment

A

systemic corticosteroids are typically used to control this disease

35
Q

Epidermolysis Bullosa Etiology

A

a general term for about 20 genetic or hereditary variety of diseases
characterise are formation of blisters
IgG deposits are commonly found in sub-basement membrane tissues and Type 7 collagen

36
Q

Epidermolysis Bullosa clinical features

A

bulla formation from minor trauma
blisters may be widespread and severe, and may result in scarring and atrophy
Oral lesions are common in the recessive forms of disease and uncommon in the acquired form

37
Q

Epidermolysis Bullosa treatment

A

avoidance of trauma, supportive measures, and chemotherapeutic agents such as corticosteroids, vitamin E, phenytoin, retinoids, dapsone, immunosupressive agents